Skip to main content
Menu
US

AlphaLISA SureFire Ultra Human Total AXIN-2 Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Ultra™ Human Total AXIN-2 assay is a sandwich immunoassay for quantitative detection of total AXIN-2 in cellular lysates using Alpha Technology.

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT

The AlphaLISA™ SureFire® Ultra™ Human Total AXIN-2 assay is a sandwich immunoassay for quantitative detection of total AXIN-2 in cellular lysates using Alpha Technology.

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Product Variants
Unit Size: 100 assay points
Part #:
ALSU-TAXIN2-A-HV
List Price
USD 694.00
Your online price:
Unit Size: 500 assay points
Part #:
ALSU-TAXIN2-A500
List Price
USD 2,346.00
Your online price:
Unit Size: 10,000 assay points
Part #:
ALSU-TAXIN2-A10K
List Price
USD 14,270.00
Your online price:
Unit Size: 50,000 assay points
Part #:
ALSU-TAXIN2-A50K
List Price
USD 46,060.00
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

AXIN-2 is a scaffold protein crucial for the WNT/β-catenin signaling pathway, promoting β-catenin degradation by assembling the destruction complex with APC, GSK3β, and CK1α. Dysregulation of AXIN-2 disrupts β-catenin levels, driving cancers such as colorectal cancer. Loss of AXIN-2 function is also observed in breast cancer and neuroblastoma.

The AlphaLISA SureFire Ultra Human Total AXIN-2 Detection Kit is a sandwich immunoassay for the quantitative detection of total AXIN-2 in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

AlphaLISA SureFire Ultra kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Ultra
Detection Modality
Alpha
Protocol Time
2h at RT
Shipping Conditions
Shipped in Blue Ice
Target
AXIN-2
Target Class
Phosphoproteins
Target Species
Human
Technology
Alpha
Therapeutic Area
Oncology
Unit Size
100 assay points

Video gallery

How it works

Total-AlphaLISA SureFire Ultra assay principle

The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.

The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Assay Principle Total AlphaLISA SureFire Ultra

 

Total-AlphaLISA SureFire Ultra two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells' viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2plates-assay-protocol-AlphaLISA-Surefire-Ultra.jpg
Total-AlphaLISA SureFire Ultra one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.

1 plate assay protocol AlphaLISA Surefire Ultra

Assay validation

Increase of Total AXIN-2 in SW 48 cells

SW 48 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of a Tankyrase inhibitor (XAV-939) for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AXIN-2 and ERK1/2 Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with XAV-939 triggered a dose-dependent increase in the levels of AXIN-2 while Total ERK1/2 levels remain unchanged

Pharmacological Validation (activator) of Total AXIN-2
Increase of Total AXIN-2 in MCF7 cells

MCF7 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of a Tankyrase inhibitor (XAV-939) for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AXIN-2 and Cofilin Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. The lysate was further diluted 1:10 for the Cofilin assay. For the detection step, 10 µL of cell lysate (approximately 4,000 cells for AXIN-2 Total and 400 cells for Cofilin Total) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with XAV-939 triggered a dose-dependent increase in the levels of AXIN-2 while Total Cofilin levels remain unchanged.

Increase of AXIN-2 Total levels in MCF7 Cells
Increase of Total AXIN-2 in G007-LK treated cells

SW 48 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of a Tankyrase inhibitor (G007-LK) for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AXIN-2 and Cofilin Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 6,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with G007-LK triggered a dose-dependent increase in the levels of AXIN-2 while Total Cofilin levels remain unchanged.

Increase of AXIN-2 Total levels in G007-LK Treated Cells
Decrease in Total AXIN-2 levels in MG132 treated cells

SW 48 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO2. The cells were treated with XAV-939 (5 µM) or XAV-939 + MG132 (5 µM) for 6 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AXIN-2 Total levels were evaluated using AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, dual treatment with XAV-939 and MG132 induced a decrease in the levels of Total AXIN-2 levels.

Decrease in Total AXIN-2 levels in MG132 Treated Cells
Specificity of AXIN-2 Total assay

Specificity of the Total AXIN-2 assay was assessed by assaying AXIN-1 and AXIN-2 recombinant human proteins.

Dilutions of recombinant AXIN-1 (Abcam, ab204090) and AXIN-2 (Abcam, ab204097) were prepared in Lysis Buffer. AXIN-2 Total levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of protein was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Total AXIN-2 assay reacts only to AXIN-2 recombinant protein with no cross-reactivity observed for AXIN-1 protein. These results demonstrate the specificity of the AXIN-2 Total assay as these two proteins share approximately 50% sequence identity.

Selectivity of AXIN-2 Total Assay
Versatility of Total AXIN-2 assay in various cell lines

Various cell lines were seeded at 40,000 cells/well in a 96-well plate in complete medium and incubated overnight at 37°C, 5% CO2. Cells were lysed with 100 µL of Lysis Buffer.

AXIN-2 Total levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

AXIN-2 Total protein expression is varied depending on cell type. AXIN-2 Total is highly expressed in colorectal cancer cell lines e.g. SW 48 and is not expressed in skin cancer cell line A431.

Versatility of Total AXIN-2 Assay In Various Cell Lines

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Scroll Icon